CYB5RL: A Potential Drug Target and Biomarker (G606495)

Target Name: CYB5RL

NCBI ID: G606495

CYB5RL

CYB5RL: A Potential Drug Target and Biomarker

CYB5RL (NB5R5_HUMAN) is a drug target and a biomarker that has been identified for its role in the development and progression of various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, leading to a growing body of research that has identified new potential drug approaches and therapies.

The CYB5RL protein is a member of the NB5R family, which is known for its role in the production of nitric oxide, a critical signaling molecule that regulates various physiological processes in the body. The NB5R family has also been implicated in the regulation of cell death , inflammation, and other cellular processes that are important for maintaining tissue health and responding to environmental stimuli.

CYB5RL is a 51-kDa protein that is expressed in various tissues and cells throughout the body. It is primarily localized to the endoplasmic reticulum (ER), a protein synthesis and modification system that plays a central role in the delivery and processing of proteins to the cell surface. CYB5RL is also known to be involved in the regulation of cellular processes such as cell adhesion, migration, and invasion, as well as in the modulation of cellular signaling pathways that are important for cell survival and proliferation.

The identification of CYB5RL as a potential drug target and biomarker has been based on a growing body of research that has shown its involvement in the development and progression of various diseases, including cancer. Several studies have shown that CYB5RL is involved in the regulation of cellular processes that are critical for the growth, survival, and progression of cancer cells. For example, studies have shown that CYB5RL is involved in the regulation of cell adhesion, a process that allows cancer cells to stick to each other and form tumors.

In addition, CYB5RL has also been shown to be involved in the regulation of the Wnt signaling pathway, a critical pathway that is involved in the development and progression of many diseases, including cancer. The Wnt signaling pathway is a trans-membrane protein that is involved in the regulation of cell growth, differentiation, and survival, and it is thought to play a key role in the development of cancer.

CYB5RL is also involved in the regulation of theNotch signaling pathway, which is involved in the regulation of cell survival and proliferation. TheNotch signaling pathway is a trans-membrane protein that is involved in the regulation of cell signaling pathways that are important for cell survival and proliferation.

The identification of CYB5RL as a potential drug target and biomarker has led to a growing body of research that is focused on identifying new drug approaches and therapies that can target CYB5RL and its downstream signaling pathways. This research is being done in a variety of cellular contexts , including in vitro and in vivo systems, and it has the potential to lead to new treatments and therapies for a variety of diseases.

In conclusion, CYB5RL is a drug target and biomarker that has the potential to lead to new treatments and therapies for a variety of diseases. Its unique structure and function as a member of the NB5R family make it an attractive target for researchers to study, and the growing body of research that has identified its involvement in the regulation of various cellular processes and signaling pathways makes it an attractive candidate for drug development. Further studies are needed to fully understand the role of CYB5RL in the development and progression of disease and to identify new drug approaches and therapies that can target it effectively.

Protein Name: Cytochrome B5 Reductase Like

Functions: NADH-cytochrome b5 reductases are involved in desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction

The "CYB5RL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYB5RL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets